ELATE GROUP, INC. UNDERWRITING AGREEMENTUnderwriting Agreement • February 12th, 2024 • Elate Group, Inc. • Trucking & courier services (no air) • New York
Contract Type FiledFebruary 12th, 2024 Company Industry JurisdictionThe undersigned, Elate Group, Inc., a company incorporated under the laws of Delaware (the “Company”), hereby confirms its agreement (this “Agreement”) with the several underwriters (such underwriters, including the Representative (as defined below) of the “Underwriters,” and each an “Underwriter”) named in Schedule I hereto for which EF Hutton LLC is acting as representative to the several Underwriters (the “Representative” and if there are no Underwriters other than the Representative, references to multiple Underwriters shall be disregarded and the term Representative as used herein shall have the same meaning as Underwriter) on the terms and conditions set forth herein.
480,000 SHARES of Common Stock PRE-FUNDED WARRANTS EXERCIsABLE INTO 1,424,760 SHARES OF COMMON STOCK Series A WARRANTS EXERCIsABLE INTO 3,809,520 SHARES OF cOMMON sTOCK AND Series B WARRANTS EXERCIsABLE INTO 3,809,520 SHARES OF cOMMON sTOCK PERASO INC.Underwriting Agreement • February 9th, 2024 • Peraso Inc. • Semiconductors & related devices • New York
Contract Type FiledFebruary 9th, 2024 Company Industry JurisdictionThe undersigned, Peraso Inc., a company incorporated under the laws of Delaware (the “Company”), hereby confirms its agreement (this “Agreement”) with the several underwriters (such underwriters, including the Representative (as defined below), the “Underwriters” and each an “Underwriter”) named in Schedule I hereto for which Ladenburg Thalmann & Co. Inc. is acting as representative to the several Underwriters (the “Representative” and if there are no Underwriters other than the Representative, references to multiple Underwriters shall be disregarded and the term Representative as used herein shall have the same meaning as Underwriter) on the terms and conditions set forth herein.
SHARES of Common Stock PRE-FUNDED WARRANTS EXERCIsABLE INTO ___ SHARES OF COMMON STOCK Series A WARRANTS EXERCIsABLE INTO ___ SHARES OF cOMMON sTOCK AND Series B WARRANTS EXERCIsABLE INTO ___ SHARES OF cOMMON sTOCK PERASO INC.Underwriting Agreement • February 5th, 2024 • Peraso Inc. • Semiconductors & related devices • New York
Contract Type FiledFebruary 5th, 2024 Company Industry JurisdictionThe undersigned, Peraso Inc., a company incorporated under the laws of Delaware (the “Company”), hereby confirms its agreement (this “Agreement”) with the several underwriters (such underwriters, including the Representative (as defined below), the “Underwriters” and each an “Underwriter”) named in Schedule I hereto for which Ladenburg Thalmann & Co. Inc. is acting as representative to the several Underwriters (the “Representative” and if there are no Underwriters other than the Representative, references to multiple Underwriters shall be disregarded and the term Representative as used herein shall have the same meaning as Underwriter) on the terms and conditions set forth herein.
UNDERWRITING AGREEMENTUnderwriting Agreement • January 23rd, 2024 • Peraso Inc. • Semiconductors & related devices • New York
Contract Type FiledJanuary 23rd, 2024 Company Industry JurisdictionThe undersigned, Peraso Inc., a company incorporated under the laws of Delaware (the “Company”), hereby confirms its agreement (this “Agreement”) with the several underwriters (such underwriters, including the Representative (as defined below), the “Underwriters” and each an “Underwriter”) named in Schedule I hereto for which Ladenburg Thalmann & Co. Inc. is acting as representative to the several Underwriters (the “Representative” and if there are no Underwriters other than the Representative, references to multiple Underwriters shall be disregarded and the term Representative as used herein shall have the same meaning as Underwriter) on the terms and conditions set forth herein.
ELATE GROUP, INC. UNDERWRITING AGREEMENTUnderwriting Agreement • January 22nd, 2024 • Elate Group, Inc. • Trucking & courier services (no air) • New York
Contract Type FiledJanuary 22nd, 2024 Company Industry JurisdictionThe undersigned, Elate Group, Inc., a company incorporated under the laws of Delaware (the “Company”), hereby confirms its agreement (this “Agreement”) with the several underwriters (such underwriters, including the Representative (as defined below) of the “Underwriters,” and each an “Underwriter”) named in Schedule I hereto for which EF Hutton LLC is acting as representative to the several Underwriters (the “Representative” and if there are no Underwriters other than the Representative, references to multiple Underwriters shall be disregarded and the term Representative as used herein shall have the same meaning as Underwriter) on the terms and conditions set forth herein.
ELATE GROUP, INC. UNDERWRITING AGREEMENTUnderwriting Agreement • January 17th, 2024 • Elate Group, Inc. • Trucking & courier services (no air) • New York
Contract Type FiledJanuary 17th, 2024 Company Industry JurisdictionThe undersigned, Elate Group, Inc., a company incorporated under the laws of Delaware (the “Company”), hereby confirms its agreement (this “Agreement”) with the several underwriters (such underwriters, including the Representative (as defined below) of the “Underwriters,” and each an “Underwriter”) named in Schedule I hereto for which EF Hutton LLC is acting as representative to the several Underwriters (the “Representative” and if there are no Underwriters other than the Representative, references to multiple Underwriters shall be disregarded and the term Representative as used herein shall have the same meaning as Underwriter) on the terms and conditions set forth herein.
ELATE GROUP, INC. UNDERWRITING AGREEMENTUnderwriting Agreement • December 27th, 2023 • Elate Group, Inc. • Trucking & courier services (no air) • New York
Contract Type FiledDecember 27th, 2023 Company Industry JurisdictionThe undersigned, Elate Group, Inc., a company incorporated under the laws of Delaware (the “Company”), hereby confirms its agreement (this “Agreement”) with the several underwriters (such underwriters, including the Representative (as defined below) of the “Underwriters,” and each an “Underwriter”) named in Schedule I hereto for which EF Hutton, LLC is acting as representative to the several Underwriters (the “Representative” and if there are no Underwriters other than the Representative, references to multiple Underwriters shall be disregarded and the term Representative as used herein shall have the same meaning as Underwriter) on the terms and conditions set forth herein.
SEQLL INC. (to be renamed Atlantic International Corp.) UNDERWRITING AGREEMENTUnderwriting Agreement • November 7th, 2023 • SeqLL, Inc. • Services-help supply services • New York
Contract Type FiledNovember 7th, 2023 Company Industry JurisdictionThe undersigned, SeqLL Inc. (to be renamed Atlantic International Corp. in connection with the transactions contemplated hereby), a company incorporated under the laws of Delaware (the “Company”), hereby confirms its agreement (this “Agreement”) with the several underwriters (such underwriters, including the Representative (as defined below) of the “Underwriters,” and each an “Underwriter”) named in Schedule I hereto for which EF Hutton, division of Benchmark Investments, LLC is acting as representative to the several Underwriters (the “Representative” and if there are no Underwriters other than the Representative, references to multiple Underwriters shall be disregarded and the term Representative as used herein shall have the same meaning as Underwriter) on the terms and conditions set forth herein.
UNDERWRITING AGREEMENTUnderwriting Agreement • October 18th, 2023 • SeqLL, Inc. • Services-help supply services • New York
Contract Type FiledOctober 18th, 2023 Company Industry Jurisdiction
UNDERWRITING AGREEMENTUnderwriting Agreement • September 5th, 2023 • Syra Health Corp • Services-employment agencies • New York
Contract Type FiledSeptember 5th, 2023 Company Industry JurisdictionThe undersigned, Syra Health Corp., a Delaware corporation (the “Company”), hereby confirms its agreement (this “Agreement”) with the several underwriters named herein (the “Underwriters” and each an “Underwriter”), for whom Kingswood, a division of Kingswood Capital Partners, LLC is acting as lead managing underwriter, bookrunner and representative (in such capacity, the “Representative,” and if there are no underwriters other than the Representative, the term Representative as used herein shall have the same meaning as Underwriter) to issue and sell to the Underwriters an aggregate of [●] immediately detachable units of the Company (“Units”) to be sold by the Company (the “Firm Securities”). Each Unit consists of one share of Class A common stock, par value $0.001 per share (“Share”), and one non-tradeable warrant of the Company (“Warrant”), where each Warrant entitles the holder to purchase one Share for an exercise price of $[●] per share, subject to adjustment as provided in that
SHARES of Common Stock, [_____] pre-funded warrants (EXERCISABLE FOR [_____] SHARES of Common Stock) and [_____] Warrants (EXERCISABLE FOR [_____] SHARES OF COMMON STOCK) OF SEQLL INC. (to be renamed Atlantic International Corp.)Underwriting Agreement • August 15th, 2023 • SeqLL, Inc. • Services-help supply services • New York
Contract Type FiledAugust 15th, 2023 Company Industry Jurisdiction
shares of Common Stock Pre-Funded Warrants to Purchase ______________ shares of Common Stock Warrants to Purchase ______________ Shares of Common Stock (___________ shares of Common Stock issuable upon exercise of the Pre-Funded Warrants and...Underwriting Agreement • June 7th, 2023 • Coeptis Therapeutics Holdings, Inc. • Biological products, (no disgnostic substances) • New York
Contract Type FiledJune 7th, 2023 Company Industry JurisdictionThe undersigned, Coeptis Therapeutics Holdings, Inc., a Delaware corporation (collectively with its subsidiaries, including, without limitation, all entities disclosed or described in the Registration Statement as being subsidiaries of Coeptis Therapeutics Holdings, Inc., the “Company”), hereby confirms its agreement (this “Agreement”) with the several underwriters (such underwriters, including the Representative (as defined below), the “Underwriters” and each an “Underwriter”) named in Schedule I hereto for which Ladenburg Thalmann & Co. Inc. is acting as representative to the several Underwriters (the “Representative” and if there are no Underwriters other than the Representative, references to multiple Underwriters shall be disregarded and the term Representative as used herein shall have the same meaning as Underwriter) on the terms and conditions set forth herein.
●] UNITS EACH UNIT CONSISTING OF ONE SHARE OF COMMON STOCK AND ONE WARRANT TO PURCHASE ONE SHARE OF COMMON STOCK ARCH THERAPEUTICS, INC. UNDERWRITING AGREEMENTUnderwriting Agreement • January 23rd, 2023 • Arch Therapeutics, Inc. • Surgical & medical instruments & apparatus • New York
Contract Type FiledJanuary 23rd, 2023 Company Industry JurisdictionThe undersigned, Arch Therapeutics, Inc., a Nevada corporation (collectively with its subsidiaries and affiliates, including, without limitation, all entities disclosed or described in the Registration Statement (as defined below) as being subsidiaries or affiliates of Arch Therapeutics, Inc., if any, the “Company”), hereby confirms its agreement (this “Agreement”) with the several underwriters (such underwriters, including the Representative (as defined below), the “Underwriters” and each an “Underwriter”) named in Schedule I hereto for which Maxim Group LLC (“Maxim”) is acting as representative to the several Underwriters (in such capacity, the “Representative” and if there are no Underwriters under than the Representative, references to multiple Underwriters shall be disregarded and the term Representative as used herein shall have the same meaning as Underwriter) on the terms and conditions set forth herein.
9,800,000 SHARES of Common Stock and 19,600,000 Warrants of QUANERGY SYSTEMS, INC. UNDERWRITING AGREEMENTUnderwriting Agreement • November 2nd, 2022 • Quanergy Systems, Inc. • Motor vehicle parts & accessories • New York
Contract Type FiledNovember 2nd, 2022 Company Industry JurisdictionThe undersigned, Quanergy Systems, Inc. a company incorporated under the laws of Delaware (the “Company”), hereby confirms its agreement (this “Agreement”) with the several underwriters (such underwriters, including the Representative (as defined below), the “Underwriters” and each an “Underwriter”) named in Schedule I hereto for which Maxim Group LLC is acting as representative to the several Underwriters (the “Representative” and if there are no Underwriters other than the Representative, references to multiple Underwriters shall be disregarded and the term Representative as used herein shall have the same meaning as Underwriter) on the terms and conditions set forth herein.
UNDERWRITING AGREEMENTUnderwriting Agreement • October 24th, 2022 • NeuroBo Pharmaceuticals, Inc. • Pharmaceutical preparations • New York
Contract Type FiledOctober 24th, 2022 Company Industry JurisdictionThe undersigned, NeuroBo Pharmaceuticals, Inc., a corporation incorporated under the laws of Delaware (collectively with its subsidiaries and affiliates, including, without limitation, all entities disclosed or described in the Registration Statement as being subsidiaries or affiliates of NeuroBo Pharmaceuticals, Inc., the “Company”), hereby confirms its agreement (this “Agreement”) with the several underwriters (such underwriters, including the Representative (as defined below), the “Underwriters” and each an “Underwriter”) named in Schedule I hereto for which Ladenburg Thalmann & Co. Inc. is acting as representative to the several Underwriters (the “Representative” and if there are no Underwriters other than the Representative, references to multiple Underwriters shall be disregarded and the term Representative as used herein shall have the same meaning as Underwriter) on the terms and conditions set forth herein.
WARRANTS EXERCISABLE INTO _______ SHARES OF COMMON STOCK OF NUWELLIS, INC. UNDERWRITING AGREEMENTUnderwriting Agreement • October 12th, 2022 • Nuwellis, Inc. • Electromedical & electrotherapeutic apparatus • New York
Contract Type FiledOctober 12th, 2022 Company Industry JurisdictionThe undersigned, Nuwellis, Inc., a Delaware corporation (collectively with its subsidiaries, including, without limitation, all entities disclosed or described in the Registration Statement as being a subsidiary of Nuwellis, Inc., the “Company”), hereby confirms its agreement (this “Agreement”) with the several underwriters, if any (such underwriters, including the Representative (as defined below), the “Underwriters” and each an “Underwriter”) named in Schedule I hereto for which Ladenburg Thalmann & Co. Inc. is acting as representative to the several Underwriters (the “Representative” and if there are no Underwriters other than the Representative, references to multiple Underwriters shall be disregarded and the term Representative as used herein shall have the same meaning as Underwriter) on the terms and conditions set forth herein.
WARRANTS EXERCISABLE INTO _______ SHARES OF COMMON STOCK OF NUWELLIS, INC. UNDERWRITING AGREEMENTUnderwriting Agreement • October 11th, 2022 • Nuwellis, Inc. • Electromedical & electrotherapeutic apparatus • New York
Contract Type FiledOctober 11th, 2022 Company Industry JurisdictionThe undersigned, Nuwellis, Inc., a Delaware corporation (collectively with its subsidiaries, including, without limitation, all entities disclosed or described in the Registration Statement as being a subsidiary of Nuwellis, Inc., the “Company”), hereby confirms its agreement (this “Agreement”) with the several underwriters, if any (such underwriters, including the Representative (as defined below), the “Underwriters” and each an “Underwriter”) named in Schedule I hereto for which Ladenburg Thalmann & Co. Inc. is acting as representative to the several Underwriters (the “Representative” and if there are no Underwriters other than the Representative, references to multiple Underwriters shall be disregarded and the term Representative as used herein shall have the same meaning as Underwriter) on the terms and conditions set forth herein.
WARRANT SHARES) ANDUnderwriting Agreement • October 7th, 2022 • Chembio Diagnostics, Inc. • Pharmaceutical preparations • New York
Contract Type FiledOctober 7th, 2022 Company Industry JurisdictionThe undersigned, Chembio Diagnostics, Inc., a company incorporated under the laws of Nevada (collectively with its subsidiaries and affiliates, including, without limitation, all entities disclosed or described in the Registration Statement as being subsidiaries or affiliates of Chembio Diagnostics, Inc., the “Company”), hereby confirms its agreement (this “Agreement”) with the several underwriters (such underwriters, including the Representative (as defined below), the “Underwriters” and each an “Underwriter”) named in Schedule I hereto for which Craig-Hallum Capital Group LLC is acting as representative to the several Underwriters (the “Representative” and if there are no Underwriters other than the Representative, references to multiple Underwriters shall be disregarded and the term Representative as used herein shall have the same meaning as Underwriter) on the terms and conditions set forth herein.
WARRANTS EXERCISABLE INTO _______ SHARES OF COMMON STOCK OF NUWELLIS, INC. UNDERWRITING AGREEMENTUnderwriting Agreement • September 30th, 2022 • Nuwellis, Inc. • Electromedical & electrotherapeutic apparatus • New York
Contract Type FiledSeptember 30th, 2022 Company Industry JurisdictionThe undersigned, Nuwellis, Inc., a Delaware corporation (collectively with its subsidiaries, including, without limitation, all entities disclosed or described in the Registration Statement as being a subsidiary of Nuwellis, Inc., the “Company”), hereby confirms its agreement (this “Agreement”) with the several underwriters, if any (such underwriters, including the Representative (as defined below), the “Underwriters” and each an “Underwriter”) named in Schedule I hereto for which Ladenburg Thalmann & Co. Inc. is acting as representative to the several Underwriters (the “Representative” and if there are no Underwriters other than the Representative, references to multiple Underwriters shall be disregarded and the term Representative as used herein shall have the same meaning as Underwriter) on the terms and conditions set forth herein.
MED-X, INC. UNDERWRITING AGREEMENT [●] Shares of Common StockUnderwriting Agreement • September 19th, 2022 • Med-X, Inc. • Pharmaceutical preparations • New York
Contract Type FiledSeptember 19th, 2022 Company Industry JurisdictionMed-X, Inc., a Nevada corporation (the “Company”), proposes, subject to the terms and conditions stated herein, to issue and sell to the underwriters named in Schedule I hereto (the “Underwriters,” or each, an “Underwriter”), for whom EF Hutton, division of Benchmark Investments, LLC (“EF Hutton”), is acting as the representative (the “Representative”), an aggregate of [●] shares (the “Firm Shares”) of common stock, par value $0.001 per share, of the Company (the “Common Stock”). The Company also proposes to issue and sell to the Underwriters, upon the terms and conditions set forth herein, up to an additional [●] shares of Common Stock (the “Option Shares”), representing 15% of the Firm Shares, as may be necessary to cover over-allotments made in connection with the offering. The Option Shares and the Firm Shares are referred to collectively herein as the “Securities.”
UNDERWRITING AGREEMENTUnderwriting Agreement • September 2nd, 2022 • Auto Parts 4Less Group, Inc. • Services-business services, nec • New York
Contract Type FiledSeptember 2nd, 2022 Company Industry JurisdictionThe undersigned, Auto Parts 4Less Group, Inc., a company incorporated under the laws of Nevada (collectively with its subsidiaries and affiliates, including, without limitation, all entities disclosed or described in the Registration Statement as being subsidiaries or affiliates of Auto Parts 4Less Group, Inc., the “Company”), hereby confirms its agreement (this “Agreement”) with the several underwriters (such underwriters, including the Representative (as defined below), the “Underwriters” and each an “Underwriter”) named in Schedule I hereto for which Maxim Group LLC is acting as representative to the several Underwriters (the “Representative” and if there are no Underwriters other than the Representative, references to multiple Underwriters shall be disregarded and the term Representative as used herein shall have the same meaning as Underwriter) on the terms and conditions set forth herein.
26,680,720 SHARES OF COMMON STOCK, PRE-FUNDED WARRANTS TO PURCHASE 590,000 SHARES OF COMMON STOCK AND WARRANTS TO PURCHASE 27,270,720 SHARES OF COMMON STOCK OF CLARUS THERAPEUTICS HOLDINGS, INC. UNDERWRITING AGREEMENTUnderwriting Agreement • April 27th, 2022 • Clarus Therapeutics Holdings, Inc. • Biological products, (no disgnostic substances) • New York
Contract Type FiledApril 27th, 2022 Company Industry JurisdictionThe undersigned, Clarus Therapeutics Holdings, Inc., a company incorporated under the laws of Delaware (the “Company”), hereby confirms its agreement (this “Agreement”) with the several underwriters (such underwriters, including the Representative (as defined below), the “Underwriters” and each an “Underwriter”) named in Schedule I hereto for which Maxim Group LLC is acting as representative to the several Underwriters (the “Representative” and if there are no Underwriters other than the Representative, references to multiple Underwriters shall be disregarded and the term Representative as used herein shall have the same meaning as Underwriter) on the terms and conditions set forth herein.
SHARES OF COMMON STOCK, PRE-FUNDED WARRANTS TO PURCHASE SHARES OF COMMON STOCK AND WARRANTS TO PURCHASE SHARES OF COMMON STOCK OF CLARUS THERAPEUTICS HOLDINGS, INC. UNDERWRITING AGREEMENTUnderwriting Agreement • April 25th, 2022 • Clarus Therapeutics Holdings, Inc. • Biological products, (no disgnostic substances) • New York
Contract Type FiledApril 25th, 2022 Company Industry JurisdictionThe undersigned, Clarus Therapeutics Holdings, Inc., a company incorporated under the laws of Delaware (the “Company”), hereby confirms its agreement (this “Agreement”) with the several underwriters (such underwriters, including the Representative (as defined below), the “Underwriters” and each an “Underwriter”) named in Schedule I hereto for which Maxim Group LLC is acting as representative to the several Underwriters (the “Representative” and if there are no Underwriters other than the Representative, references to multiple Underwriters shall be disregarded and the term Representative as used herein shall have the same meaning as Underwriter) on the terms and conditions set forth herein.
SHARES OF COMMON STOCK, PRE-FUNDED WARRANTS TO PURCHASE SHARES OF COMMON STOCK AND WARRANTS TO PURCHASE SHARES OF COMMON STOCK OF CLARUS THERAPEUTICS HOLDINGS, INC. UNDERWRITING AGREEMENTUnderwriting Agreement • April 21st, 2022 • Clarus Therapeutics Holdings, Inc. • Biological products, (no disgnostic substances) • New York
Contract Type FiledApril 21st, 2022 Company Industry JurisdictionThe undersigned, Clarus Therapeutics Holdings, Inc., a company incorporated under the laws of Delaware (the “Company”), hereby confirms its agreement (this “Agreement”) with the several underwriters (such underwriters, including the Representative (as defined below), the “Underwriters” and each an “Underwriter”) named in Schedule I hereto for which Maxim Group LLC is acting as representative to the several Underwriters (the “Representative” and if there are no Underwriters other than the Representative, references to multiple Underwriters shall be disregarded and the term Representative as used herein shall have the same meaning as Underwriter) on the terms and conditions set forth herein.
UNDERWRITING AGREEMENTUnderwriting Agreement • April 11th, 2022 • SOS Hydration Inc. • Beverages • New York
Contract Type FiledApril 11th, 2022 Company Industry JurisdictionThe undersigned, SOS Hydration Inc., a company incorporated under the laws of Nevada (collectively with its subsidiaries and affiliates, including, without limitation, all entities disclosed or described in the Registration Statement as being subsidiaries or affiliates of SOS Hydration Inc., the “Company”), hereby confirms its agreement (this “Agreement”) with the several underwriters (such underwriters, including the Representative (as defined below), the “Underwriters” and each an “Underwriter”) named in Schedule I hereto for which Maxim Group LLC is acting as representative to the several Underwriters (the “Representative” and if there are no Underwriters other than the Representative, references to multiple Underwriters shall be disregarded and the term Representative as used herein shall have the same meaning as Underwriter) on the terms and conditions set forth herein.
UNDERWRITING AGREEMENTUnderwriting Agreement • March 23rd, 2022 • Aclarion, Inc. • Services-medical laboratories • New York
Contract Type FiledMarch 23rd, 2022 Company Industry JurisdictionThe undersigned, Aclarion, Inc., a company incorporated under the laws of Delaware (collectively with its subsidiaries and affiliates, including, without limitation, all entities disclosed or described in the Registration Statement as being subsidiaries or affiliates of Aclarion, Inc., the “Company”), hereby confirms its agreement (this “Agreement”) with the several underwriters (such underwriters, including the Representative (as defined below), the “Underwriters” and each an “Underwriter”) named in Schedule I hereto for which Maxim Group LLC is acting as representative to the several Underwriters (the “Representative” and if there are no Underwriters other than the Representative, references to multiple Underwriters shall be disregarded and the term Representative as used herein shall have the same meaning as Underwriter) on the terms and conditions set forth herein.
UNDERWRITING AGREEMENTUnderwriting Agreement • March 4th, 2022 • Aclarion, Inc. • Services-medical laboratories • New York
Contract Type FiledMarch 4th, 2022 Company Industry JurisdictionThe undersigned, Aclarion, Inc., a company incorporated under the laws of Delaware (collectively with its subsidiaries and affiliates, including, without limitation, all entities disclosed or described in the Registration Statement as being subsidiaries or affiliates of Aclarion, Inc., the “Company”), hereby confirms its agreement (this “Agreement”) with the several underwriters (such underwriters, including the Representative (as defined below), the “Underwriters” and each an “Underwriter”) named in Schedule I hereto for which Maxim Group LLC is acting as representative to the several Underwriters (the “Representative” and if there are no Underwriters other than the Representative, references to multiple Underwriters shall be disregarded and the term Representative as used herein shall have the same meaning as Underwriter) on the terms and conditions set forth herein.
DERMATA THERAPEUTICS, INC. UNDERWRITING AGREEMENTUnderwriting Agreement • February 4th, 2022 • Dermata Therapeutics, Inc. • Pharmaceutical preparations • New York
Contract Type FiledFebruary 4th, 2022 Company Industry JurisdictionThe undersigned, Dermata Therapeutics, Inc., a company incorporated under the laws of Delaware (the “Company”), hereby confirms its agreement (this “Agreement”) with the several underwriters (such underwriters, including the Representative (as defined below), the “Underwriters” and each an “Underwriter”) named in Schedule I hereto for which Maxim Group LLC is acting as representative to the several Underwriters (the “Representative” and if there are no Underwriters other than the Representative, references to multiple Underwriters shall be disregarded and the term Representative as used herein shall have the same meaning as Underwriter) on the terms and conditions set forth herein.
UNDERWRITING AGREEMENTUnderwriting Agreement • December 27th, 2021 • Nexgel, Inc. • Surgical & medical instruments & apparatus • New York
Contract Type FiledDecember 27th, 2021 Company Industry JurisdictionThe undersigned, NexGel, Inc., a company incorporated under the laws of Delaware (collectively with its subsidiaries and affiliates, including, without limitation, all entities disclosed or described in the Registration Statement as being subsidiaries or affiliates of NexGel, Inc., the “Company”), hereby confirms its agreement (this “Agreement”) with the several underwriters (such underwriters, including the Representative (as defined below), the “Underwriters” and each an “Underwriter”) named in Schedule I hereto for which Maxim Group LLC is acting as representative to the several Underwriters (the “Representative” and if there are no Underwriters other than the Representative, references to multiple Underwriters shall be disregarded and the term Representative as used herein shall have the same meaning as Underwriter) on the terms and conditions set forth herein.
UNDERWRITING AGREEMENT Dated _______________, 202__ Between APPTECH PAYMENTS CORP. (a Delaware corporation) And EF HUTTON, Division of Benchmark Investments, LLC as Representative of the several Underwriters named on Scheduleattached heretoUnderwriting Agreement • December 17th, 2021 • AppTech Payments Corp. • Services-prepackaged software • New York
Contract Type FiledDecember 17th, 2021 Company Industry JurisdictionThe undersigned, AppTech Payments Corp., a company incorporated under the laws of Nevada (the “Company”), hereby confirms its agreement (this “Agreement”) with the several underwriters (such underwriters, including the Representative (as defined below), the “Underwriters” and each an “Underwriter”) named in Schedule I hereto for which EF Hutton, division of Benchmark Investments, LLC (“EF Hutton”) is acting as representative to the several Underwriters (in such capacity, the “Representative” and if there are no Underwriters other than the Representative, references to multiple Underwriters shall be disregarded and the term Representative as used herein shall have the same meaning as Underwriter) on the terms and conditions set forth herein.
UNDERWRITING AGREEMENTUnderwriting Agreement • August 31st, 2021 • SeqLL, Inc. • Laboratory analytical instruments • New York
Contract Type FiledAugust 31st, 2021 Company Industry JurisdictionThe undersigned, SeqLL Inc., a company incorporated under the laws of Delaware (collectively with its subsidiaries and affiliates, including, without limitation, all entities disclosed or described in the Registration Statement as being subsidiaries or affiliates of SeqLL Inc., the “Company”), hereby confirms its agreement (this “Agreement”) with the several underwriters (such underwriters, including the Representative (as defined below), the “Underwriters” and each an “Underwriter”) named in Schedule I hereto for which Maxim Group LLC is acting as representative to the several Underwriters (the “Representative” and if there are no Underwriters other than the Representative, references to multiple Underwriters shall be disregarded and the term Representative as used herein shall have the same meaning as Underwriter) on the terms and conditions set forth herein.
SHARES OF COMMON STOCK AND ___________ WARRANTS TO PURCHASE ___________ SHARES OF COMMON STOCK OF DERMATA THERAPEUTICS, INC. UNDERWRITING AGREEMENTUnderwriting Agreement • August 6th, 2021 • Dermata Therapeutics, Inc. • Pharmaceutical preparations • New York
Contract Type FiledAugust 6th, 2021 Company Industry JurisdictionThe undersigned, Dermata Therapeutics, Inc., a company incorporated under the laws of Delaware (the “Company”), hereby confirms its agreement (this “Agreement”) with the several underwriters (such underwriters, including the Representative (as defined below), the “Underwriters” and each an “Underwriter”) named in Schedule I hereto for which Maxim Group LLC is acting as representative to the several Underwriters (the “Representative” and if there are no Underwriters other than the Representative, references to multiple Underwriters shall be disregarded and the term Representative as used herein shall have the same meaning as Underwriter) on the terms and conditions set forth herein.
ABVC BIOPHARMA, INC. UNDERWRITING AGREEMENT 1,000,000 Units Consisting of 1,000,000 Shares of Common Stock 1,000,000 Series A Warrants to Purchase 1,000,000 Shares of Common Stock And 1,000,000 Series B Warrants to Purchase 1,000,000 Shares of Common...Underwriting Agreement • July 29th, 2021 • Abvc Biopharma, Inc. • Pharmaceutical preparations • New York
Contract Type FiledJuly 29th, 2021 Company Industry JurisdictionABVC BIOPHARMA, INC., a Delaware corporation (the “Company”), proposes, subject to the terms and conditions stated herein, to issue and sell to the underwriters named in Schedule I hereto (the “Underwriters,” or each, an “Underwriter”), for whom WallachBeth Capital, LLC is acting as representative (the “Representative”), an aggregate of 1,000,000 Units (the “Firm Units”), each Firm Unit consisting of (a) one share of the Company’s common stock, $0.001 par value per share (the “Common Stock”), (b) one Series A warrant (the “Series A Warrants”) to purchase one share of Common Stock and (c) one Series B warrant to purchase one share of common stock (the “Series B Warrants,” and together with the Series A Warrants, the “Warrants” and each a “Warrant”). The 1,000,000 shares of Common Stock referred to in this Section are hereinafter referred to as the “Firm Shares” and the Warrants referred to in this Section are hereinafter referred to as the “Firm Warrants,” and together with the Firm Uni
GROM SOCIAL ENTERPRISES, INC. 2,409,639 UNITS CONSISTING OF 2,409,639 SHARES OF COMMON STOCK AND WARRANTS (EXERCISABLE FOR UP TO 2,409,639 SHARES OF COMMON STOCK) UNDERWRITING AGREEMENTUnderwriting Agreement • June 22nd, 2021 • Grom Social Enterprises, Inc. • Services-computer programming, data processing, etc. • New York
Contract Type FiledJune 22nd, 2021 Company Industry JurisdictionThe undersigned, Grom Social Enterprises, Inc., a company incorporated under the laws of Florida (collectively with its subsidiaries and affiliates, including, without limitation, all entities disclosed or described in the Registration Statement as being subsidiaries or affiliates of Grom Social Enterprises, Inc., the “Company”), hereby confirms its agreement (this “Agreement”) with the several underwriters (such underwriters, including the Representative (as defined below), the “Underwriters” and each an “Underwriter”) named in Schedule I hereto for which EF Hutton, division of Benchmark Investments, LLC, is acting as representative to the several Underwriters (in such capacity, the “Representative” and if there are no Underwriters other than the Representative, references to multiple Underwriters shall be disregarded and the term Representative as used herein shall have the same meaning as Underwriters) on the terms and conditions set forth herein.
UNDERWRITING AGREEMENTUnderwriting Agreement • May 28th, 2021 • SeqLL, Inc. • Laboratory analytical instruments • New York
Contract Type FiledMay 28th, 2021 Company Industry JurisdictionThe undersigned, SeqLL Inc., a company incorporated under the laws of Delaware (collectively with its subsidiaries and affiliates, including, without limitation, all entities disclosed or described in the Registration Statement as being subsidiaries or affiliates of SeqLL Inc., the “Company”), hereby confirms its agreement (this “Agreement”) with the several underwriters (such underwriters, including the Representative (as defined below), the “Underwriters” and each an “Underwriter”) named in Schedule I hereto for which Maxim Group LLC is acting as representative to the several Underwriters (the “Representative” and if there are no Underwriters other than the Representative, references to multiple Underwriters shall be disregarded and the term Representative as used herein shall have the same meaning as Underwriter) on the terms and conditions set forth herein.